| P50 | author | Conor Farren | Q56542924 |
| P2093 | author name string | Roger D Weiss | |
| | Kevin P Hill | |
| P2860 | cites work | The genetics of bipolar disorder: genome ‘hot regions,’ genes, new potential candidates and future directions | Q22251105 |
| | Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study | Q28259349 |
| | Two-year outcomes for interpersonal and social rhythm therapy in individuals with bipolar I disorder | Q28270795 |
| | Matching Alcoholism Treatments to Client Heterogeneity: Project MATCH posttreatment drinking outcomes | Q28300322 |
| | The functional neuroanatomy of bipolar disorder: a review of neuroimaging findings | Q33206291 |
| | Genetic and environmental influences on alcohol, caffeine, cannabis, and nicotine use from early adolescence to middle adulthood | Q33750946 |
| | Effects of clozapine on substance use in patients with schizophrenia and schizoaffective disorder: a retrospective survey | Q33827207 |
| | Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis | Q34093476 |
| | Low level of response to alcohol as a predictor of future alcoholism | Q34348860 |
| | A randomized controlled study of cognitive therapy for relapse prevention for bipolar affective disorder: outcome of the first year | Q34531152 |
| | Neurogenetic adaptive mechanisms in alcoholism | Q34559392 |
| | A randomized, double-blind, placebo-controlled pilot study of naltrexone in outpatients with bipolar disorder and alcohol dependence | Q34578600 |
| | The genetics of bipolar affective disorder | Q34586798 |
| | Bipolar disorder and comorbid alcoholism: prevalence rate and treatment considerations | Q34588955 |
| | Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions | Q34645025 |
| | Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group | Q34727272 |
| | A double-blind, placebo-controlled pilot trial of quetiapine for the treatment of Type A and Type B alcoholism | Q35354770 |
| | Improving the care of individuals with schizophrenia and substance use disorders: consensus recommendations | Q36267882 |
| | A 6-month, double-blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid-cycling bipolar disorder and Co-occurring substance abuse or dependence | Q36653440 |
| | Effect of naltrexone and ondansetron on alcohol cue-induced activation of the ventral striatum in alcohol-dependent people | Q36824245 |
| | Genetic factors influencing alcohol dependence | Q37117548 |
| | Molecular genetics of alcohol dependence and related endophenotypes | Q37214936 |
| | Sweet liking phenotype, alcohol craving and response to naltrexone treatment in alcohol dependence | Q37288935 |
| | A "community-friendly" version of integrated group therapy for patients with bipolar disorder and substance dependence: a randomized controlled trial | Q37326437 |
| | Genetics of bipolar disorder: successful start to a long journey | Q37368587 |
| | Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. | Q38407349 |
| | Promising treatments for women with comorbid PTSD and substance use disorders | Q39691195 |
| | The effect of alcohol and substance abuse on the course of bipolar affective disorder | Q41017655 |
| | A population-based twin study of alcoholism in women | Q41097114 |
| | Quetiapine decreases alcohol consumption, craving, and psychiatric symptoms in dually diagnosed alcoholics | Q42163532 |
| | The safety profile of naltrexone in the treatment of alcoholism. Results from a multicenter usage study. The Naltrexone Usage Study Group | Q42546054 |
| | Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders | Q42655103 |
| | Predictive factors for relapse after an integrated inpatient treatment programme for unipolar depressed and bipolar alcoholics. | Q42882603 |
| | A double-blind, placebo-controlled study with quetiapine as adjunct therapy with lithium or divalproex in bipolar I patients with coexisting alcohol dependence | Q42971800 |
| | The effect of moderate and excessive alcohol use on the course and outcome of patients with bipolar disorders: a prospective cohort study | Q43178328 |
| | Comorbidity between bipolar disorder and alcohol use disorder: association of dopamine and serotonin gene polymorphisms | Q43195471 |
| | Olanzapine treatment for patients with schizophrenia and substance abuse | Q43845727 |
| | Naltrexone for alcohol dependence: a randomized controlled trial | Q43849956 |
| | The use of divalproex in alcohol relapse prevention: a pilot study | Q44070882 |
| | Impact of concurrent alcohol misuse on symptom presentation of acute mania at initial evaluation | Q44272772 |
| | Gender differences in prevalence, risk, and clinical correlates of alcoholism comorbidity in bipolar disorder | Q44427295 |
| | Oral topiramate for treatment of alcohol dependence: a randomised controlled trial | Q44454640 |
| | Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey | Q44986547 |
| | Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study | Q45209951 |
| | The impact of co-morbid alcohol use disorder in bipolar patients | Q46400090 |
| | Effects of co-occurring alcohol abuse on the course of bipolar disorder following a first hospitalization for mania | Q46630225 |
| | A randomized, double-blind, placebo-controlled add-on trial of quetiapine in outpatients with bipolar disorder and alcohol use disorders. | Q46724427 |
| | Endophenotypes successfully lead to gene identification: results from the collaborative study on the genetics of alcoholism | Q46845849 |
| | Profound decreases in dopamine release in striatum in detoxified alcoholics: possible orbitofrontal involvement | Q46899798 |
| | Naltrexone in patients with bipolar disorder and alcohol dependence. | Q48439294 |
| | A randomized, double-blind, placebo-controlled clinical trial of acamprosate in alcohol-dependent individuals with bipolar disorder: a preliminary report | Q48732780 |
| | Gender differences in outcome at 2-year follow-up of treated bipolar and depressed alcoholics. | Q50787486 |
| | Anomalous prefrontal-subcortical activation in familial pediatric bipolar disorder: a functional magnetic resonance imaging investigation. | Q50995292 |
| | A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness. | Q51919476 |
| | Impulsivity and phase of illness in bipolar disorder. | Q51951356 |
| | Types of alcoholics, I. Evidence for an empirically derived typology based on indicators of vulnerability and severity. | Q52042144 |
| | Group therapy for patients with bipolar disorder and substance dependence: results of a pilot study. | Q52278480 |
| | Treatment response of bipolar and unipolar alcoholics to an inpatient dual diagnosis program. | Q52291676 |
| | Decline in age of drinking onset in Ireland, gender and per capita alcohol consumption. | Q52298711 |
| | Naltrexone utility in depressed alcoholics. | Q53955693 |
| | Efficacy of Naltrexone and Acamprosate for Alcoholism Treatment: A Meta-Analysis | Q56481671 |
| | A Randomized Trial on the Efficacy of Group Psychoeducation in the Prophylaxis of Recurrences in Bipolar Patients Whose Disease Is in Remission | Q57612892 |
| | Utilization of Psychosocial Treatments by Patients Diagnosed with Bipolar Disorder and Substance Dependence | Q58277383 |
| | Psychosocial Treatments for Cocaine Dependence: National Institute on Drug Abuse Collaborative Cocaine Treatment Study | Q60682821 |
| | Prevention of alcohol withdrawal seizures with carbamazepine and valproic acid | Q61650044 |
| | Clinical importance of age at onset in type 1 and type 2 primary alcoholics | Q68746546 |
| | Valproate treatment of alcohol withdrawal and mania | Q71465899 |
| | Co-occurrence and contransmission of affective disorders and alcoholism in families | Q71669130 |
| | Use of naltrexone in the treatment of alcohol use disorders in patients with concomitant major mental illness | Q73184455 |
| | A randomized study of family-focused psychoeducation and pharmacotherapy in the outpatient management of bipolar disorder | Q73918315 |
| | The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia | Q73967057 |
| | A randomized trial of integrated group therapy versus group drug counseling for patients with bipolar disorder and substance dependence | Q79485933 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | alcoholism | Q15326 |
| | bipolar disorder | Q131755 |
| | substance use disorder | Q7632070 |
| P304 | page(s) | 659-666 | |
| P577 | publication date | 2012-12-01 | |
| P1433 | published in | Current Psychiatry Reports | Q25245507 |
| P1476 | title | Bipolar disorder and alcohol use disorder: a review | |
| P478 | volume | 14 | |